Skip to main content
Ovarian Cancer
Patient-Reported Outcomes Following Treatment with Niraparib
Read More
Ovarian Cancer
Safety and Efficacy of Lenvatinib + Pembrolizumab in Patients with Ovarian Cancer: LEAP-005
Read More
Ovarian Cancer
Phase 3 Trial of Tumor Treating Fields and Concomitant Weekly Paclitaxel for the Treatment of Platinum-Resistant Ovarian Cancer
Read More
Ovarian Cancer
Assessing Olaparib Combined with Pegylated Liposomal Doxorubicin for Treatment of Platinum-Resistant Ovarian Cancer
Read More
Ovarian Cancer
Efficacy of Niraparib in Potentially Difficult-to-Treat Patients with Newly Diagnosed Ovarian Cancer Based on BRCAwt Status
Read More
Ovarian Cancer
In Women with Platinum-Sensitive Ovarian Cancer, There Was No Difference in PFS Between Platinum-Based Chemotherapy and Olaparib plus Cediranib
Read More
Ovarian Cancer
Impact of Visible Residual Disease, Other Risk Factors on Advanced Ovarian Cancer Progression and Death: Real-World Evidence
Read More
Page 3 of 3
Results 21 - 27 of 27